Discovery of p-Terphenyl Metabolites as Potential Phosphodiesterase PDE4D Inhibitors from the Coral-Associated Fungus Aspergillus sp. ITBBc1

Mar Drugs. 2022 Oct 28;20(11):679. doi: 10.3390/md20110679.

Abstract

Chemical investigation of the fermentation extract of the coral-associated fungus Aspergillus sp. ITBBc1 led to the discovery of five unreported p-terphenyl derivatives, sanshamycins A-E (1-5), together with five previously described analogues, terphenyllin (6), 3-hydroxyterphenyllin (7), candidusin A (8), 4,5-dimethoxycandidusin A (9), and candidusin C (10). Their structures were elucidated by HRESIMS data and NMR spectroscopic analysis. Compound 1 represents the first example of p-terphenyls with an aldehyde substitution on the benzene ring. Compounds 2-4 feature varying methoxyl and isopentenyl substitutions, while compound 5 features a five-membered lactone linked to a biphenyl. These findings expand the chemical diversity of the family of p-terphenyl natural products. Compounds 1-6 and 9 were evaluated for their inhibitory activity against type 4 phosphodiesterase (PDE4), which is a fascinating drug target for treatment of inflammatory, respiratory, and neurological diseases. Compound 3 was the most potent and exhibited PDE4D inhibitory activity with an IC50 value of 5.543 µM.

Keywords: Aspergillus sp.; coral-associated fungus; natural products; p-terphenyls; phosphodiesterase PDE4D inhibitor.

MeSH terms

  • Agaricales*
  • Animals
  • Anthozoa* / metabolism
  • Aspergillus / chemistry
  • Biological Products* / metabolism
  • Biological Products* / pharmacology
  • Molecular Structure
  • Phosphodiesterase Inhibitors / metabolism
  • Phosphoric Diester Hydrolases / metabolism

Substances

  • Phosphodiesterase Inhibitors
  • Biological Products
  • Phosphoric Diester Hydrolases